Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 23;58(3):339.
doi: 10.3390/medicina58030339.

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report

Affiliations
Case Reports

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report

Mateja Sladič et al. Medicina (Kaunas). .

Abstract

Persistent infection with human papillomavirus (HPV) causes almost all cervical precancerous lesions and cancers. Bivalent, quadrivalent, and nonavalent HPV vaccines effectively prevent high-grade cervical intraepithelial neoplasia (CIN3). The effectiveness of HPV vaccination against CIN3 is 97-100% in HPV-naïve populations and 44-61% in the overall population. Although HPV vaccination has substantially reduced the incidence of cervical cancers, several cases of precancerous cervical lesions in HPV-vaccinated patients have been reported. We report the clinical case of a 19-year-old woman whose first Pap smear was diagnosed as a high-grade squamous intraepithelial lesion (HSIL) after quadrivalent HPV vaccination. Colposcopy and cervical biopsy were performed, revealing HSIL/CIN3. Our multidisciplinary team decided to take a conservative approach with follow-up visits with cervical biopsies of this young patient. After six months, spontaneous regression of high-grade cervical dysplasia was observed. Although HPV immunization has shown to be extremely effective in preventing a high proportion of cervical precancerous lesions and cervical cancers, HPV vaccines do not protect against all oncogenic high-risk HPV genotypes. Consequently, healthcare providers must encourage HPV-vaccinated women to still regularly attend national cervical screening programs.

Keywords: Papanicolaou test; cervical intraepithelial neoplasia; papillomavirus vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
Cytology image of HSIL. Separated cells in a Pap smear presented typical features of high-grade dyskaryosis: slightly enlarged nuclei with hyperchromasia, increased nuclear/cytoplasmic ratios in most cells, and irregularly dispersed chromatin (magnification: 40×).
Figure 2
Figure 2
Histopathology image of CIN3/HSIL. The epithelium lacked maturation and consisted of highly atypical cells with hyperchromatic nuclei with increased mitotic activity. The nuclear/cytoplasmic ratio was also increased. (a) Hematoxylin and eosin staining (magnification 100×). (b) Immunohistochemical staining with p16 revealed a diffuse reaction, which was highly suggestive of CIN3 (magnification 100×).

Similar articles

Cited by

References

    1. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am. J. Epidemiol. 2003;157:218–226. doi: 10.1093/aje/kwf180. - DOI - PubMed
    1. Tognon M., Tagliapietra A., Magagnoli F., Mazziotta C., Oton-Gonzalez L., Lanzillotti C., Vesce F., Contini C., Rotondo J.C., Martini F. Investigation on Spontaneous Abortion and Human Papillomavirus Infection. Vaccines. 2020;8:473. doi: 10.3390/vaccines8030473. - DOI - PMC - PubMed
    1. Braaten K.P., Laufer M.R. Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev. Obstet. Gynecol. 2008;1:2–10. - PMC - PubMed
    1. Joura E.A., Ault K.A., Bosch F.X., Brown D., Cuzick J., Ferris D., Garland S.M., Giuliano A.R., Hernandez-Avila M., Huh W., et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol. Biomark. Prev. 2014;23:1997–2008. doi: 10.1158/1055-9965.EPI-14-0410. - DOI - PubMed
    1. Tilston P. Anal human papillomavirus and anal cancer. J. Clin. Pathol. 1997;50:625–634. doi: 10.1136/jcp.50.8.625. - DOI - PMC - PubMed

Publication types

MeSH terms